US Stock MarketDetailed Quotes

NRIX Nurix Therapeutics

Watchlist
  • 15.450
  • +0.450+3.00%
Close Feb 28 16:00 ET
  • 15.449
  • -0.001-0.01%
Post 20:01 ET
1.17BMarket Cap-5.36P/E (TTM)

Nurix Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Nov 30, 2024
(Q4)Nov 30, 2024
(Q3)Aug 31, 2024
(Q2)May 31, 2024
(Q1)Feb 29, 2024
(FY)Nov 30, 2023
(Q4)Nov 30, 2023
(Q3)Aug 31, 2023
(Q2)May 31, 2023
(Q1)Feb 28, 2023
Total revenue
-29.15%54.55M
-12.37%13.28M
-31.84%12.59M
-60.58%12.09M
30.74%16.59M
99.31%76.99M
123.49%15.16M
71.13%18.47M
168.33%30.68M
31.85%12.69M
Operating revenue
-29.15%54.55M
-12.37%13.28M
-31.84%12.59M
-60.58%12.09M
30.74%16.59M
99.31%76.99M
123.49%15.16M
71.13%18.47M
168.33%30.68M
31.85%12.69M
Cost of revenue
Gross profit
Operating expense
15.31%267.58M
28.84%77.94M
14.91%67.2M
5.56%60.63M
11.08%61.8M
4.29%232.05M
9.05%60.49M
1.69%58.48M
0.51%57.44M
6.25%55.64M
Selling and administrative expenses
7.09%45.94M
-0.58%10.72M
10.31%11.72M
0.27%11.71M
20.14%11.8M
12.91%42.9M
15.08%10.78M
8.98%10.62M
20.97%11.68M
6.43%9.82M
-General and administrative expense
7.09%45.94M
-0.58%10.72M
10.31%11.72M
0.27%11.71M
20.14%11.8M
12.91%42.9M
15.08%10.78M
8.98%10.62M
20.97%11.68M
6.43%9.82M
Research and development costs
17.17%221.63M
35.22%67.22M
15.93%55.48M
6.90%48.92M
9.14%50.01M
2.52%189.15M
7.82%49.71M
0.20%47.86M
-3.64%45.76M
6.21%45.82M
Operating profit
-37.38%-213.03M
-42.62%-64.66M
-36.49%-54.61M
-81.36%-48.54M
-5.28%-45.22M
15.67%-155.06M
6.89%-45.33M
14.35%-40.01M
41.45%-26.77M
-0.49%-42.95M
Net non-operating interest income expense
77.49%19.73M
81.05%6.12M
89.34%5.74M
64.15%4.08M
70.84%3.79M
216.94%11.12M
71.21%3.38M
200.30%3.03M
692.36%2.49M
951.66%2.22M
Non-operating interest income
77.49%19.73M
81.05%6.12M
89.34%5.74M
64.15%4.08M
70.84%3.79M
216.94%11.12M
71.21%3.38M
200.30%3.03M
692.36%2.49M
951.66%2.22M
Other net income (expense)
Income before tax
-34.28%-193.3M
-39.53%-58.54M
-32.16%-48.87M
-83.12%-44.46M
-1.71%-41.43M
20.19%-143.95M
10.19%-41.96M
19.09%-36.98M
46.53%-24.28M
4.23%-40.73M
Income tax
270K
8K
82K
90K
90K
0
0
0
0
0
Net income
-34.47%-193.57M
-39.55%-58.55M
-32.38%-48.96M
-83.49%-44.55M
-1.93%-41.52M
20.19%-143.95M
10.19%-41.96M
19.09%-36.98M
46.53%-24.28M
4.23%-40.73M
Net income continuous Operations
-34.47%-193.57M
-39.55%-58.55M
-32.38%-48.96M
-83.49%-44.55M
-1.93%-41.52M
20.19%-143.95M
10.19%-41.96M
19.09%-36.98M
46.53%-24.28M
4.23%-40.73M
Minority interest income
Net income attributable to the parent company
-34.47%-193.57M
-39.55%-58.55M
-32.38%-48.96M
-83.49%-44.55M
-1.93%-41.52M
20.19%-143.95M
10.19%-41.96M
19.09%-36.98M
46.53%-24.28M
4.23%-40.73M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-34.47%-193.57M
-39.55%-58.55M
-32.38%-48.96M
-83.49%-44.55M
-1.93%-41.52M
20.19%-143.95M
10.19%-41.96M
19.09%-36.98M
46.53%-24.28M
4.23%-40.73M
Basic earnings per share
-8.68%-2.88
2.60%-0.75
1.47%-0.67
-57.78%-0.71
-1.33%-0.76
28.57%-2.65
11.49%-0.77
24.44%-0.68
55.45%-0.45
21.05%-0.75
Diluted earnings per share
-8.68%-2.88
2.60%-0.75
1.47%-0.67
-57.78%-0.71
-1.33%-0.76
28.57%-2.65
11.49%-0.77
24.44%-0.68
55.45%-0.45
21.05%-0.75
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Nov 30, 2024(Q4)Nov 30, 2024(Q3)Aug 31, 2024(Q2)May 31, 2024(Q1)Feb 29, 2024(FY)Nov 30, 2023(Q4)Nov 30, 2023(Q3)Aug 31, 2023(Q2)May 31, 2023(Q1)Feb 28, 2023
Total revenue -29.15%54.55M-12.37%13.28M-31.84%12.59M-60.58%12.09M30.74%16.59M99.31%76.99M123.49%15.16M71.13%18.47M168.33%30.68M31.85%12.69M
Operating revenue -29.15%54.55M-12.37%13.28M-31.84%12.59M-60.58%12.09M30.74%16.59M99.31%76.99M123.49%15.16M71.13%18.47M168.33%30.68M31.85%12.69M
Cost of revenue
Gross profit
Operating expense 15.31%267.58M28.84%77.94M14.91%67.2M5.56%60.63M11.08%61.8M4.29%232.05M9.05%60.49M1.69%58.48M0.51%57.44M6.25%55.64M
Selling and administrative expenses 7.09%45.94M-0.58%10.72M10.31%11.72M0.27%11.71M20.14%11.8M12.91%42.9M15.08%10.78M8.98%10.62M20.97%11.68M6.43%9.82M
-General and administrative expense 7.09%45.94M-0.58%10.72M10.31%11.72M0.27%11.71M20.14%11.8M12.91%42.9M15.08%10.78M8.98%10.62M20.97%11.68M6.43%9.82M
Research and development costs 17.17%221.63M35.22%67.22M15.93%55.48M6.90%48.92M9.14%50.01M2.52%189.15M7.82%49.71M0.20%47.86M-3.64%45.76M6.21%45.82M
Operating profit -37.38%-213.03M-42.62%-64.66M-36.49%-54.61M-81.36%-48.54M-5.28%-45.22M15.67%-155.06M6.89%-45.33M14.35%-40.01M41.45%-26.77M-0.49%-42.95M
Net non-operating interest income expense 77.49%19.73M81.05%6.12M89.34%5.74M64.15%4.08M70.84%3.79M216.94%11.12M71.21%3.38M200.30%3.03M692.36%2.49M951.66%2.22M
Non-operating interest income 77.49%19.73M81.05%6.12M89.34%5.74M64.15%4.08M70.84%3.79M216.94%11.12M71.21%3.38M200.30%3.03M692.36%2.49M951.66%2.22M
Other net income (expense)
Income before tax -34.28%-193.3M-39.53%-58.54M-32.16%-48.87M-83.12%-44.46M-1.71%-41.43M20.19%-143.95M10.19%-41.96M19.09%-36.98M46.53%-24.28M4.23%-40.73M
Income tax 270K8K82K90K90K00000
Net income -34.47%-193.57M-39.55%-58.55M-32.38%-48.96M-83.49%-44.55M-1.93%-41.52M20.19%-143.95M10.19%-41.96M19.09%-36.98M46.53%-24.28M4.23%-40.73M
Net income continuous Operations -34.47%-193.57M-39.55%-58.55M-32.38%-48.96M-83.49%-44.55M-1.93%-41.52M20.19%-143.95M10.19%-41.96M19.09%-36.98M46.53%-24.28M4.23%-40.73M
Minority interest income
Net income attributable to the parent company -34.47%-193.57M-39.55%-58.55M-32.38%-48.96M-83.49%-44.55M-1.93%-41.52M20.19%-143.95M10.19%-41.96M19.09%-36.98M46.53%-24.28M4.23%-40.73M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -34.47%-193.57M-39.55%-58.55M-32.38%-48.96M-83.49%-44.55M-1.93%-41.52M20.19%-143.95M10.19%-41.96M19.09%-36.98M46.53%-24.28M4.23%-40.73M
Basic earnings per share -8.68%-2.882.60%-0.751.47%-0.67-57.78%-0.71-1.33%-0.7628.57%-2.6511.49%-0.7724.44%-0.6855.45%-0.4521.05%-0.75
Diluted earnings per share -8.68%-2.882.60%-0.751.47%-0.67-57.78%-0.71-1.33%-0.7628.57%-2.6511.49%-0.7724.44%-0.6855.45%-0.4521.05%-0.75
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
LINTEX
920106
+30.00%
LINGOOD
833284
+29.98%
NTGEC
870436
+29.98%
4
CG MED EQUIP.
838810
+29.97%
5
Jiayu Holding
300117
+20.48%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call